Olanzapine-Induced Weight Gain in Patients With First-Episode Schizophrenia: A Double-Blind, Placebo-Controlled Study of Fluoxetine Addition

Michael Poyurovsky, Artashes Pashinian, Irit Gil‐Ad, Rachel Maayan, Michael Schneidman, Camil Fuchs, Abraham Weizman

American Journal of Psychiatry · 2002 · 102 citations · 6 references

Abstract

These results suggest that fluoxetine coadministration is clinically ineffective and cannot attenuate olanzapine-induced weight gain.

References

6